QR 678- The new age solution to hair loss

Ludhiana, November 6, 2021: Male and female pattern hair loss, also known as androgenic alopecia, continues to remain a prominent area of concern, especially in the age groups of 25 and onwards. Clinicians and cosmetologists have been investigating modalities for a long time now. While nonsurgical hair regrowth treatments like over-the-counter topical minoxidil, prescription oral finasteride, platelet-rich plasma (PRP) injections and light & laser therapy treatments help reduce hair fall when used in combination, they do leave adverse side effects. Meet QR678- a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response“ QR code. 678 in Morse Code signifies “there is no answer.
According to a press release, the therapy was invented by Dr.Debraj Shome - Clinical Scientist & Leader, R&D Team, QR678 and Dr.Rinky Kapoor; Both are celebrity cosmetic surgeons from India and co -founders of  The Esthetic Clinics  which are a chain of top class dermatology & plastic surgery centers located in various cities in India. They observed that male pattern baldness, known as Androgenic Alopecia characterised by progressive hair loss in men growing at a rampant rate of 58% in males aged 30-50 years which initiated their urge to research and find a solution to this cosmetic issue leading to the invention of QR 678. The therapy curbs hair fall and increases the thickness, the number and density of existing hair follicles, offering greater hair coverage to the ones with alopecia. They ran comparative trials between the QR 678 and PRP treatments with QR 678®treatment causing almost 300% better results than the PRP. The therapy also increases the uptake of traditional hair transplant by 50 %.
The hair-regrowth treatments available in the market, currently have many limitations; they cannot revive hair beyond a certain stage. QR678 is a process where growth factors are injected in the hair follicles, which not only arrests hair fall but also stimulates hair growth. QR678 is a non-surgical, pain-free and non-invasive procedure for the hair regrowth treatment which has shown very good results in over 21,000+ patients. The QR678 therapy has been awarded the prestigious composition and mechanism of administration patent from the United States of America in 2017 and the Indian FDA gave an approval for commercial manufacturing & sale in March 2019. The therapy is also FDA approved in EU, UK, Kuwait and pending approvals in other countries.  The Food & Drug Administration (FDA) approval means its effectiveness and efficacy has been reviewed by the CDER and it has been established that its benefits outweighs its potential risks.
In the EU and UK markets, the QR678 therapy launch has been initiated, after which the majority of the hair clinics in these markets will have access to the therapy. At present, the product is made at the QR678® facilities which are located in Korea; manufacturing units are being set up in Europe as we speak and there is a European entity which deals in distribution all around the world. 
Soon, QR678 would be filing a fresh patent globally, as the product is undergoing overhauling. The patent would be even more efficacious. The team is also coming up with their own level of hair care products including nutraceuticals shampoos, serums and the likes.
Growth factors, hormonal imbalance, lifestyle choices, stress are all leading causes for hair loss; QR 678 bridges the gap as a proven solution.